Contribution of failure of normal growth regulatory controls to the development of hematologic malignancies; development of new flow cytometric applications for research and clinical use. This includes basic and translational studies on applications for monitoring receptor/ligand binding, multiparameter functional studies, minimal residual disease detection, stem cell isolation and identification, and transplantation monitoring.
Principal Investigator: Jonni S. Moore, PhD